CC BY-NC-ND 4.0 · Endosc Int Open 2023; 11(12): E1153-E1160
DOI: 10.1055/a-2197-3731
Original article

Analysis of adverse events with lumen apposing metal stents for drainage of pancreatic fluid collections

1   Gastroenterology, Wake Forest University School of Medicine, Winston-Salem, United States (Ringgold ID: RIN12279)
,
Robert Dorrell
1   Gastroenterology, Wake Forest University School of Medicine, Winston-Salem, United States (Ringgold ID: RIN12279)
,
Madison Nguyen
2   Department of Medicine, Virginia Commonwealth University, Richmond, United States (Ringgold ID: RIN6889)
,
Greg Russell
3   Biostatistics, Wake Forest University School of Medicine, Winston-Salem, United States (Ringgold ID: RIN12279)
,
John Gilliam
1   Gastroenterology, Wake Forest University School of Medicine, Winston-Salem, United States (Ringgold ID: RIN12279)
› Author Affiliations

Abstract

Background and study aims Innovations in endoscopic management of pancreatic fluid collections (PFCs) using lumen apposing metal stents (LAMS) have rendered it a preferred approach for drainage of PFCs. These advances have not come without concern for adverse events (AEs). We present our experience with LAMS for drainage of PFCs and analyze factors that contribute to LAMS-related AEs.

Patients and methods From November 2015 to October 2021, a retrospective analysis was performed of patients undergoing endoscopic management of PFCs using LAMS. All AEs were classified as either early (<48 hours) or late (>48 hours). Univariate and multivariate analysis were performed using logistic regression to assess the relationship between independent variables and AEs.

Results A total of 119 patients with symptomatic PFCs underwent endoscopic drainage with LAMS. There were 16 AEs (12.4%). These included systemic inflammatory response syndrome (SIRS) (n=2), stent occlusion (n=5), bleeding (n=7), and stent migration (n=2). Univariate analysis of risk of AEs showed that no variables approached statistical significance. Of the seven patients who developed bleeding, five had pseudoaneurysms following LAMS placement and underwent angioembolization by an interventional radiologist. The average time to bleeding was 9.3 days (standard deviation 7.3) with all bleeding events occurring within 3 weeks. In a multivariate model, pseudocysts and presence of paracolic gutter extension were associated with an increased risk of bleeding.

Conclusions Endoscopists should be aware of the risk factors for LAMS-related bleeding and tailor their drainage strategy, including utilization of plastic stents for drainage of pseudocysts and adherence to a strict imaging interval and follow-up protocol.



Publication History

Received: 29 July 2023

Accepted after revision: 19 October 2023

Article published online:
12 December 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Thompson CC, Kumar N, Slattery J. et al. A standardized method for endoscopic necrosectomy improves complication and mortality rates. Pancreatology 2016; 16: 66-72 DOI: 10.1016/j.pan.2015.12.001. (PMID: 26748428)
  • 2 Fugazza A, Sethi A, Trindade AJ. et al. International multicenter comprehensive analysis of adverse events associated with lumen-apposing metal stent placement for pancreatic fluid collection drainage. Gastrointest Endosc 2020; 91: 574-583
  • 3 Bang JY, Hasan M, Navaneethan U. et al. Lumen-apposing metal stents (LAMS) for pancreatic fluid collection (PFC) drainage: may not be business as usual. Gut 2017; 66: 2054-2056 DOI: 10.1136/gutjnl-2016-312812. (PMID: 27582509)
  • 4 Nayar M, Leeds JS, Oppong K. Lumen-apposing metal stents for drainage of pancreatic fluid collections: does timing of removal matter?. Gut 2022; 71: 850-853 DOI: 10.1136/gutjnl-2021-325812. (PMID: 35217579)
  • 5 Amato A, Tarantino I, Facciorusso A. et al. Real-life multicentre study of lumen-apposing metal stent for EUS-guided drainage of pancreatic fluid collections. Gut 2022; 71: 1050-1052 DOI: 10.1136/gutjnl-2022-326880. (PMID: 35193984)
  • 6 Facciorusso A, Amato A, Crinò SF. et al. Definition of a hospital volume threshold to optimize outcomes after drainage of pancreatic fluid collections with lumen-apposing metal stents: a nationwide cohort study. Gastrointest Endosc 2022; 95: 1158-1172
  • 7 Facciorusso A, Amato A, Crinò SF. et al. Nomogram for prediction of adverse events after lumen-apposing metal stent placement for drainage of pancreatic fluid collections. Dig Endosc 2022; 34: 1459-1470 DOI: 10.1111/den.14354. (PMID: 35599610)
  • 8 Brimhall B, Han S, Tatman PD. et al. Increased incidence of pseudoaneurysm bleeding with lumen-apposing metal stents compared to double-pigtail plastic stents in patients with peripancreatic fluid collections. Clin Gastroenterol Hepatol 2018; 16: 1521-1528
  • 9 Banks PA, Bollen TL, Dervenis C. et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62: 102-111 DOI: 10.1136/gutjnl-2012-302779. (PMID: 23100216)
  • 10 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454 DOI: 10.1016/j.gie.2009.10.027. (PMID: 20189503)
  • 11 Charlson ME, Pompei P, Ales KL. et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383 DOI: 10.1016/0021-9681(87)90171-8. (PMID: 3558716)
  • 12 Chen Y-I, Yang J, Friedland S. et al. Lumen apposing metal stents are superior to plastic stents in pancreatic walled-off necrosis: a large international multicenter study. Endosc Int Open 2019; 7: E347-E354 DOI: 10.1055/a-0828-7630. (PMID: 30834293)
  • 13 Stefanovic S, Degroote H, Hindryckx P. Reduction of LAMS-related adverse events with accumulating experience in a large-volume tertiary referral center. J Clin Med 2023; 12: 1037
  • 14 Yang D, Perbtani YB, Mramba LK. et al. Safety and rate of delayed adverse events with lumen-apposing metal stents (LAMS) for pancreatic fluid collections: a multicenter study. Endosc Int Open 2018; 6: E1267-E1275
  • 15 Chandrasekhara V, Barthet M, Devière J. et al. Safety and efficacy of lumen-apposing metal stents versus plastic stents to treat walled-off pancreatic necrosis: systematic review and meta-analysis. Endosc Int Open 2020; 8: E1639-e1653 DOI: 10.1055/a-1243-0092. (PMID: 33140020)
  • 16 Garcia-Alonso FJ, Sanchez-Ocana R, Peñas-Herrero I. et al. Cumulative risks of stent migration and gastrointestinal bleeding in patients with lumen-apposing metal stents. Endoscopy 2018; 50: 386-395
  • 17 Abdallah M, Vantanasiri K, Young S. et al. Visceral artery pseudoaneurysms in necrotizing pancreatitis: risk of early bleeding with lumen-apposing metal stents. Gastrointest Endosc 2022; 95: 1150-1157
  • 18 Aslam S, Ansari Z, Alani M. et al. Coaxial double-pigtail stent placement: a simple solution to decrease bleeding risk associated with lumen-apposing metal stent?. Cureus 2021; 13: e15981
  • 19 Wang Z, Wu X, Zhao S. et al. The role of co-axially placed double-pigtail stents within lumen-apposing metal stents in draining pancreatic fluid collections. Gastrointest Endosc 2018; 88: 409-410
  • 20 Shamah SP, Sahakian AB, Chapman CG. et al. Double pigtail stent placement as an adjunct to lumen-apposing metal stentsfor drainage of pancreatic fluid collections may not affect outcomes: A multicenter experience. Endosc Ultrasound 2022; 11: 53-58 DOI: 10.4103/EUS-D-21-00030. (PMID: 35102901)
  • 21 Vanek P, Falt P, Vitek P. et al. EUS-guided transluminal drainage using lumen-apposing metal stents with or without coaxial plastic stents for treatment of walled-off necrotizing pancreatitis: a prospective bicentric randomized controlled trial. Gastrointest Endosc 2023; 97: 1070-1080 DOI: 10.1016/j.gie.2022.12.026. (PMID: 36646148)